Product
Ecnoglutide
Aliases
GLP-1 analogue, Oral ecnoglutide tablet, XW003, XW004
4 clinical trials
3 indications
Indication
Weight ManagementIndication
Type 2 Diabetes MellitusIndication
ObesityClinical trial
A Phase 3, Multi-center, Randomized, Double-Blind and Placebo-controlled Study to Evaluate the Efficacy and Safety of XW003 in Adults With Overweight or Obesity (SLIMMER)Status: Active (not recruiting), Estimated PCD: 2025-01-22
Clinical trial
A Phase 3, Multi-center, Open-label, Randomized Study to Evaluate the Efficacy and Safety of XW003 Versus Dulaglutide in Patients With T2DM Inadequately Controlled by MetforminStatus: Active (not recruiting), Estimated PCD: 2024-10-03
Clinical trial
A Phase 3, Multi-center, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of XW003 in Patients With T2DM Inadequately Controlled by Diet and Exercise AloneStatus: Active (not recruiting), Estimated PCD: 2024-10-21
Clinical trial
A Phase 1, Randomised, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ecnoglutide Tablet in Healthy Adult ParticipantsStatus: Recruiting, Estimated PCD: 2024-07-01